​

Bionano Genomics (BNGO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BNGO Stock Forecast

Bionano Genomics (BNGO) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $8.00, with a high of $8.00 and a low of $8.00. This represents a 327.81% increase from the last price of $1.87.

- $1 $2 $3 $4 $5 $6 $7 $8 High: $8 Avg: $8 Low: $8 Last Closed Price: $1.87

BNGO Stock Rating

Bionano Genomics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (57.14%), 3 Hold (42.86%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 3 4 Strong Sell Sell Hold Buy Strong Buy

BNGO Price Target Upside V Benchmarks

TypeNameUpside
StockBionano Genomics327.81%
SectorHealthcare Stocks 15.45%
IndustryDiagnostics & Research Stocks8.42%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$8.00
Last Closing Price$1.87$1.87$1.87
Upside/Downside--327.81%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 252----2
Sep, 252-1--3
Aug, 252-2--4
Jul, 252-2--4
Jun, 252-2--4
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 20, 2025Jason McCarthyMaxim Group$8.00$3.77112.20%327.81%
Aug 28, 2024Sung Ji NamScotiabank$1.00$0.5196.08%-46.52%
May 16, 2024Mark MassaroBTIG$2.00$1.1573.91%6.95%
May 25, 2023Bionano Genomics'sEF Hutton$175.00$65.00169.23%9258.29%
Dec 12, 2022BTIG$350.00$219.0059.82%18616.58%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 18, 2025H.C. WainwrightBuyBuyhold
Nov 18, 2024BTIGNeutralNeutralhold
Sep 10, 2024BTIGBuyNeutraldowngrade
Aug 28, 2024ScotiabankSector OutperformSector Performdowngrade
May 16, 2024BTIGBuyBuyhold
May 25, 2023EF HuttonBuyinitialise
Jan 05, 2023ScotiabankSector Outperforminitialise
Jan 25, 2021Odeon Capital Group LLCBuyBuyhold
Jan 16, 2021OppenheimerBuyBuyhold
Dec 30, 2020OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-650 $-510 $-370 $-230 $-90 $50 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.95$-2.62$-4.58$-6.81$-88.13----
Avg Forecast$-4.00$-2.48$-4.28$-396.73$-93.13$-18.57$-15.30$-4.80$6.00
High Forecast$-3.32$-2.06$-3.48$-268.85$-63.11$-12.59$-8.46$-3.25$9.76
Low Forecast$-4.92$-3.05$-5.79$-645.24$-151.47$-30.21$-22.35$-7.81$4.07
Surprise %-1.25%5.65%7.01%-98.28%-5.37%----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.50M$17.98M$27.80M$36.12M$30.78M----
Avg Forecast$8.00M$17.26M$27.69M$35.97M$28.91M$30.69M$37.48M$101.63M$138.73M
High Forecast$9.42M$20.32M$35.22M$53.31M$29.12M$45.48M$55.54M$150.60M$205.58M
Low Forecast$6.95M$14.99M$23.72M$27.05M$28.61M$23.08M$28.19M$76.43M$104.33M
Surprise %6.25%4.19%0.42%0.40%6.46%----

Net Income Forecast

$-25B $-19B $-13B $-7B $-1B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-41.14M$-72.44M$-132.60M$-232.49M$-112.02M----
Avg Forecast$-136.60M$-84.73M$-146.00M$-15.61B$-3.66B$-730.74M$-525.93M$-188.84M$204.90M
High Forecast$-113.22M$-70.23M$-118.84M$-9.18B$-2.16B$-429.85M$-288.75M$-111.08M$333.25M
Low Forecast$-168.08M$-104.26M$-197.69M$-22.04B$-5.17B$-1.03B$-763.12M$-266.60M$138.85M
Surprise %-69.89%-14.52%-9.18%-98.51%-96.94%----

BNGO Forecast FAQ

Is Bionano Genomics stock a buy?

Bionano Genomics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Bionano Genomics is a favorable investment for most analysts.

What is Bionano Genomics's price target?

Bionano Genomics's price target, set by 7 Wall Street analysts, averages $8 over the next 12 months. The price target range spans from $8 at the low end to $8 at the high end, suggesting a potential 327.81% change from the previous closing price of $1.87.

How does Bionano Genomics stock forecast compare to its benchmarks?

Bionano Genomics's stock forecast shows a 327.81% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the diagnostics & research stocks industry (8.42%).

What is the breakdown of analyst ratings for Bionano Genomics over the past three months?

  • October 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 66.67% Strong Buy, 0% Buy, 33.33% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Bionano Genomics’s EPS forecast?

Bionano Genomics's average annual EPS forecast for its fiscal year ending in December 2025 is $-18.57, marking a -78.93% decrease from the reported $-88.13 in 2024. Estimates for the following years are $-15.3 in 2026, $-4.8 in 2027, and $6 in 2028.

What is Bionano Genomics’s revenue forecast?

Bionano Genomics's average annual revenue forecast for its fiscal year ending in December 2025 is $30.69M, reflecting a -0.27% decrease from the reported $30.78M in 2024. The forecast for 2026 is $37.48M, followed by $101.63M for 2027, and $138.73M for 2028.

What is Bionano Genomics’s net income forecast?

Bionano Genomics's net income forecast for the fiscal year ending in December 2025 stands at $-731M, representing an 552.35% increase from the reported $-112M in 2024. Projections indicate $-526M in 2026, $-189M in 2027, and $204.9M in 2028.